MRNA - Spark Newswire

2 minute read

Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can’t Catch Up

October 12, 2:10 PM

Ocugen Inc. (NASDAQ: OCGN) shares were trading higher Tuesday after the Indian government approved Bharat Biotech’s COVID-19 vaccine Covaxin, for children between the ages of 2 and 18.

MRNA

1 minute read

FDA Staff Doesn’t Take Position On Moderna COVID-19 Vaccine Booster Shot; Agency Staff Says 3rd Moderna Dose Increased Antibody Response, But Didn’t Meet Another FDA Endpoint; Booster Review Now Goes To Expert Advisors

By Benzinga Newsdesk

October 12, 11:50 AM

-Dow Jones

MRNA

1 minute read

FDA
News

FDA Advisory Committee To Convene On Oct. 14 To Discuss Whether Data Presented By Moderna Support Safety, Effectiveness Of Moderna COVID-19 Vaccine For Emergency; Authorized Use As A Booster Dose At Least 6 Months After Primary Series

By Benzinga Newsdesk

October 12, 10:23 AM

https://www.fda.gov/media/152991/download

MRNA

3 minute read

Moderna Announces COVAX Exercises Option To Purchase 176.5M Additional Doses Of Moderna’s COVID-19 Vaccine For Low Income Countries In First Half Of 2022

By Bill Haddad

October 12, 9:22 AM

More than 210 million doses have now been purchased by COVAX for delivery to low income countries, including 34 million doses that will be delivered in Q4 2021 COVAX has options to purchase an additional 233 million

MRNA

1 minute read

Moderna To Seek COVID-19 Vaccine Booster Clearance In Older Adults, High-Risk Individuals

By Benzinga Newsdesk

October 12, 9:05 AM

-Reuters

MRNA

1 minute read

Moderna Says Data Supports Benefit Of Booster Dose For Its COVID-19 Vaccine ~6 Months After Second Dose To Restore Antibody Titer Levels, Reduce Number Of Breakthrough Cases

By Benzinga Newsdesk

October 12, 8:39 AM

-Reuters

MRNA

2 minute read

A Peek Into The Markets: US Stock Futures Mostly Flat Ahead Of Earnings

By Lisa Levin

October 12, 6:08 AM

Pre-open movers

ACGL

2 minute read

Moderna Won’t Share COVID-19 Vaccine Recipe With Others — Here’s Why

By Shivdeep Dhaliwal

October 12, 1:23 AM

Moderna Inc (NASDAQ: MRNA) does not plan to share the formula for making its COVID-19 vaccine, Chairman Noubar Afeyan said in a recent

BNTX

1 minute read

Cramer Likes Ford, But Suggests Waiting For Dips To Buy These Stocks

By Craig Jones

October 11, 10:00 AM

On Friday's "Mad Money Lightning Round," Jim Cramer said that he had liked Logitech International SA (NASDAQ: LOGI) since the $30s.

1 minute read

Global
News

Why New COVID-19 Vaccination-Related Rules In This Australian State Have Small Businesses Worried

By Rahul Sharan

October 11, 1:35 AM

With the state of New South Wales, including capital Sydney, officially marking an end to its 106-day lockdown, certain small business owners have decided to remain closed, with restaurants only offering takeaway services.

AZN

Feed Symbols: MRNA